LipoScience pulls in $45 million from public offering

01/30/2013 | Clinica (subscription required)

LipoScience has secured $45 million in a just-completed initial public offering. The Raleigh, N.C.-based in vitro diagnostics company plans to use about $38.6 million in expected net proceeds from the offering in part to fund its research and development projects, including initiatives to increase its Vantera system's test menu.

View Full Article in:

Clinica (subscription required)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Litigation & Investigations EMEA
Gilead Sciences
Stockely Park
Assistant General Counsel/Senior Corporate Counsel
Genentech
South San Francisco, CA
Senior Analyst Compliance
Edwards Lifesciences
Irvine, CA
Legal Counsel
Alcon
Fort Worth, TX
Director, Senior Legal Counsel
Alcon
Fort Worth, TX